Beginning in mid-February 2008, the 1997-2007 online version of the Science Watch® newsletter, ESI-Topics.com, and in-cites.com, will all be featured together on the redesigned ScienceWatch.com. All previous content from the three sites will be permanently archived, and remain accessible from any existing bookmarks to the archived pages. No new content will be added to this site. Updates and new content (updated biweekly) are available at ScienceWatch.com now.
The Thomson Corporation inin-cites logoites
ScientistsPapersInstitutionsJournalsCountriesH O M ERSS feeds


S E A R C H
incites



SCIENTISTS

Scientists
Papers
Institutions
Journals
Countries
 

The Top 10...
Analysis of...
Site Map by Fields
Overview Menu of all Interviews
Podcasts
Hot Papers published within the last 2 years
Current Classics
SCI-BYTES - What's New in Research
What's New in Research

in-cites, September 2001
Citing URL: http://www.in-cites.com/papers/dr-carl-nathan.html

Scientists

             
An essay by:
Dr. Carl Nathan
           

Dr. Carl Nathan, Stanton Griffis Professor of Medicine at the Weill Medical College of Cornell University, talks about the teachers and experiences that have shaped his career. Dr. Nathan is the author of 9 papers which have been cited a total of 7090 times, including the review, "Nitric-oxide as a secretory product of mammalian-cells," which was published in FASEB Journal, 6: (12) 3051-3064 September 1992. This particular article has been cited 2,205 times, placing it among the 20 most-cited papers of the 1990s.

"Assistant animal boy" was my entry job. For five summers during high school and Harvard College, I cleaned rabbit cages for Lester Grant, the inflammation scholar at NYU. Lester loved theater. When he wasn’t taking the lab to Shakespeare in the Park, he was playing to his students as audience. He commanded guest appearances by Lewis Thomas, Baruj Benacerraf, Jonathan Dr. Carl NathanUhr and others. Listening to them and looking through the rabbit ear chamber, I got hooked on the cataclysmic response of white cells to injured tissue. At Harvard Medical School, John David introduced me to the immune system. I saw innate immunity as the bridge between these two experiences, and the macrophage as a major span.

A drive to seek biochemical answers brought me to Manfred Karvnosky, and later to Richard Root while I was an oncology fellow at Yale. From them I learned not just how to measure the respiratory burst but how to think biochemically and quantitatively. Then came a nine-year immersion in cell biology as a faculty member at Rockefeller University with Zanvil Cohen and Samuel Silverstein.

By the time I joined Cornell, I had introduced the concepts of cytokine-mediated activation and deactivation of macrophages, helped identify the first macrophage activating factor (interferon-g ) and its therapeutic potential in man, and demonstrated the role of the respiratory burst in macrophage biology. These encounters with superoxide prepared me to embrace the hypothesis that nitric oxide (NO) is a product of the innate immune system involved in host defense. This was at a time when most scientists thought mammalian cells are neither stupid enough nor smart enough to produce toxic, inorganic radical gases: the conventional wisdom was that cells ought not to try; and if they tried, must fail.

Our lab and collaborators went on to characterize the high output pathway of NO production. We identified NO as a cytotoxic product of activated macrophages; discovered the roles of tetrahydrobiopterin, NADPH, O2, FAD, and FMN in NO synthesis; identified specific enzymatic targets for cytotoxic actions of NO; purified and cloned the inducible NO synthase (iNOS); identified calmodulin as a sub-unit of iNOS; cloned and characterized the iNOS promoter; showed the role of NF-k B and IRF-1 in iNOS induction; identified specific residues in iNOS necessary for its binding of NADPH, tetrahydrobiopterin, heme and calmodulin; revealed the mediation by NO of the antiviral action of IFNg ; produced (with John Mudgett) iNOS-deficient mice; demonstrated the contribution of iNOS to host defense against experimental tuberculosis; established that human macrophages can express iNOS; and demonstrated neuronal expression of iNOS in Alzheimer’s disease. Our goal now is to identify genes in bacterial pathogens and human tumors that help confer resistance to NO and its products, such as peroxynitrite.

Looking back over 30 years of scientific authorship, three things stand out: the unity of the questions; the diversity of approaches to answer them; and the realization that all one’s papers, however many citations ESI says they earn, will yellow, crumble and be forgottenthe best boiled down to unattributed statements in textbooks. What lives and lasts is the chain of teachers and trainees.
End of interview

Dr. Carl Nathan
Weill Medical College of Cornell University
Department of Medicine
New York, NY, USA

in-cites, September 2001
Citing URL: http://www.in-cites.com/papers/dr-carl-nathan.html


ScienceWatch.com - Tracking Trends and Perfomance in Basic Research
Go to the new ScienceWatch.com

Home | Search | Disclaimer | Terms of Use | Privacy Policy | Copyright
Contact Webmaster with questions/comments |
(c) 2008 The Thomson Corporation.